Stockscreener 앱 받기
23.63
5.39%
-1.34
시간 외 거래:
23.63
전일 마감가:
$24.97
열려 있는:
$25.01
하루 거래량:
605.40K
Relative Volume:
1.22
시가총액:
$1.10B
수익:
$722.68M
순이익/손실:
$134.71M
주가수익비율:
8.8502
EPS:
2.67
순현금흐름:
$109.94M
1주 성능:
-11.69%
1개월 성능:
-16.82%
6개월 성능:
+0.44%
1년 성능:
-48.97%
1일 변동 폭
$23.20
$25.02
1주일 범위
$23.20
$27.07
52주 변동 폭
$20.39
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
명칭
Amphastar Pharmaceuticals Inc
전화
909-980-9484
주소
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
AMPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
23.63 | 1.16B | 722.68M | 134.71M | 109.94M | 2.67 |
|
ZTS
Zoetis Inc
|
141.09 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
439.99 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-12 | 업그레이드 | Needham | Hold → Buy |
| 2025-05-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-02-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | 개시 | Wells Fargo | Equal Weight |
| 2024-03-05 | 개시 | JP Morgan | Overweight |
| 2023-11-17 | 개시 | BofA Securities | Neutral |
| 2023-07-25 | 재개 | Jefferies | Buy |
| 2022-10-21 | 재개 | Jefferies | Buy |
| 2022-07-29 | 개시 | CapitalOne | Overweight |
| 2022-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | 개시 | Northland Capital | Outperform |
| 2019-03-13 | 다운그레이드 | Needham | Buy → Hold |
| 2019-03-13 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | 재확인 | Needham | Buy |
| 2018-03-13 | 재확인 | Needham | Buy |
| 2017-12-01 | 재확인 | Needham | Buy |
| 2017-11-09 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | 재확인 | Needham | Buy |
| 2017-03-14 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | 재확인 | Needham | Buy |
| 2016-05-10 | 재확인 | Needham | Buy |
| 2016-02-19 | 개시 | Wells Fargo | Outperform |
| 2015-06-19 | 재확인 | Needham | Buy |
| 2015-06-03 | 개시 | Raymond James | Strong Buy |
| 2014-07-21 | 개시 | Needham | Buy |
모두보기
Amphastar Pharmaceuticals Inc 주식(AMPH)의 최신 뉴스
Will Amphastar Pharmaceuticals Inc. (29A) stock gain from lower interest ratesJuly 2025 Setups & Entry and Exit Point Strategies - newser.com
BofA Cuts Price Target on Amphastar Pharmaceuticals to $31 From $32 - MarketScreener
Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs - Benzinga
Can Amphastar Pharmaceuticals Inc. stock attract ESG capital inflowsMarket Volume Report & Daily Entry Point Trade Alerts - newser.com
How to monitor Amphastar Pharmaceuticals Inc. with trend dashboardsQuarterly Risk Review & Safe Capital Growth Trade Ideas - newser.com
Will Amphastar Pharmaceuticals Inc. stock recover after recent dropMarket Volume Summary & Expert Curated Trade Setups - newser.com
Amphastar Pharmaceuticals' (AMPH) Hold (C-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Will Amphastar Pharmaceuticals Inc. (29A) stock return to pre crash levels2025 Volume Leaders & Growth Focused Entry Reports - newser.com
What analysts say about Cochlear Limited OC5 stockIPO Market Watch & Zero-Cost Stock Research by Professionals - earlytimes.in
Momentum divergence signals in Amphastar Pharmaceuticals Inc. chartAnalyst Downgrade & Precise Swing Trade Entry Alerts - newser.com
Why Amphastar Pharmaceuticals Inc. stock is a value investor pickJuly 2025 Patterns & Reliable Momentum Entry Alerts - newser.com
Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference - 富途牛牛
Will Amphastar Pharmaceuticals Inc. (29A) stock beat international competitionEarnings Recap Report & Free High Return Stock Watch Alerts - newser.com
Is Amphastar Pharmaceuticals Inc. (29A) stock cheap vs fundamentalsEarnings Trend Report & Expert Approved Momentum Ideas - newser.com
Does Amphastar Pharmaceuticals Inc. stock trade at a discount to peersMarket Growth Review & Low Drawdown Investment Ideas - newser.com
Amphastar Pharmaceuticals (NASDAQ:AMPH) Director Sells 500 Shares - MarketBeat
What drives Amphastar Pharmaceuticals Inc 29A stock pricePrice Support Zones & Free Get High Impact Recommendations - earlytimes.in
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 21.35% Potential Upside - DirectorsTalk Interviews
What analysts say about Amphastar Pharmaceuticals Inc stockPrice Momentum Alerts & Small Entry Cost Portfolio - earlytimes.in
What analysts say about Amphastar Pharmaceuticals Inc 29A stockMarket Sentiment Extremes & Breakout Stock Alerts - Early Times
What drives Amphastar Pharmaceuticals Inc stock priceValue Traps to Avoid & Outstanding Return Stocks - earlytimes.in
CX Institutional Has $6.05 Million Stock Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
CX Institutional Increases Stock Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Analysts Set Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Price Target at $31.60 - MarketBeat
After Protracted Sell-Off, Amphastar Looks Like A Value Pick (NASDAQ:AMPH) - Seeking Alpha
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring 17.13% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Aug Big Picture: Is Amphastar Pharmaceuticals Inc stock a top performer YTD2025 Sector Review & Weekly Setup with ROI Potential - خودرو بانک
Tech Rally: Can Kiora Pharmaceuticals Inc maintain sales growthWeekly Stock Analysis & Real-Time Market Sentiment Reports - khodrobank.com
Amphastar Pharmaceuticals Inc (AMPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.54%
1.16%
자본화:
|
볼륨(24시간):